Brief: Cassava Sciences Q2 Basic EPS USD -0.92

Filana Therapeutics

14/08/2025 12:30

Aug 14 (Reuters) - Cassava Sciences Q2 operating expenses USD 45.392 million.

Q2 operating income USD -45.392 million

Q2 EPS USD -0.92

Q2 net income USD -44.224 million